The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck Cancer.
The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck Cancer.
复制标题
DOI:
10.1016/j.celrep.2018.12.059
复制
发表时间:
2019-01
期刊:
影响因子:
8.8
通讯作者:
Qionghua Zhu;L. Fang;Julian Heuberger;A. Kranz;J. Schipper;K. Scheckenbach;R. Vidal;D. Sunaga-Franze;M. Müller;A. Wulf‐Goldenberg;S. Sauer;W. Birchmeier
中科院分区:
文献类型:
--
作者:
Qionghua Zhu;L. Fang;Julian Heuberger;A. Kranz;J. Schipper;K. Scheckenbach;R. Vidal;D. Sunaga-Franze;M. Müller;A. Wulf‐Goldenberg;S. Sauer;W. Birchmeier
We identified a regulatory system that acts downstream of Wnt/β-catenin signaling in salivary gland and head and neck carcinomas. We show in a mouse tumor model of K14-Cre-inducedWnt/β-cateningain-of-function andBmpr1aloss-of-function mutations that tumor-propagating cells exhibit increased Mll1 activity and genome-wide increased H3K4 tri-methylation at promoters. Null mutations ofMll1in tumor mice and in xenotransplanted human head and neck tumors resulted in loss of self-renewal of tumor-propagating cells and in block of tumor formation but did not alter normal tissue homeostasis. CRISPR/Cas9 mutagenesis and pharmacological interference of Mll1 at sequences that inhibit essential protein-protein interactions or the SET enzyme active site also blocked the self-renewal of mouse and human tumor-propagating cells. Our work provides strong genetic evidence for a crucial role of Mll1 in solid tumors. Moreover, inhibitors targeting specific Mll1 interactions might offer additional directions for therapies to treat these aggressive tumors.